14-day Premium Trial Subscription Try For FreeTry Free

Explanation to Bollinger's Bands

Bollinger Bands was created by John Bollinger in the early 1980s, its purpose is to define price action relative to the assets highs and lows. This technical indicator is used to identify buy and sell signals and has proven very well in doing so.

Bollinger Bands consist of a set of three curves drawn in relation to securities prices. The middle band is a measure of the intermediate-term trend, usually a simple moving average, that serves as the base for the upper and lower bands. The interval between the upper and lower bands and the middle band is determined by volatility, typically the standard deviation of the same data that were used for the average. StockInvest.us uses Bollingers suggested 20 day average.

Middle Bollinger Band = 20-period simple moving average
Upper Bollinger Band = Middle Bollinger Band + 2 * 20-period standard deviation
Lower Bollinger Band = Middle Bollinger Band - 2 * 20-period standard deviation

BandWidth defines the current width of the band.
%b defines the current position within the band.

BandWidth = (Upper Bollinger Band - Lower Bollinger Band) / Middle Bollinger Band
%b = (Last - Lower Bollinger Band) / (Upper Bollinger Band - Lower Bollinger Band)

Live Samples:

Bollinger Bottleneck Buy Pattern 1
Bollinger Bottleneck Buy Pattern 2
Bollinger Bottleneck Sell Pattern

Bottlenecks in bandwidth indicate an upcoming change. Break up through the moving average line or continuous movements above the moving average line indicate a break up, and vice versa.

Source: http://www.bollingerbands.com

RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CADL
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Volatile ride for Candel Therapeutics, Inc. stock price on Wednesday moving between $9.44 and $10.83
(Updated on May 08, 2024)

Buy or Hold candidate since Apr 01, 2024 Gain 518.86% PDF

The Candel Therapeutics, Inc. stock price gained 12.93% on the last trading day (Wednesday, 8th May 2024), rising from $9.59 to $10.83. During the last trading day the stock fluctuated 14.68% from a day low at $9.44 to a day high of $10.83. The price has risen in 8 of the last 10 days and is up by 79.01% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 373 thousand more shares were traded than the day before. In total, 1 million shares were bought and sold for approximately $12.29 million.

The stock has broken the very wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $9.73, a level that may pose a second chance to hit a runner. According to fan-theory $13.42 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CADL Signals & Forecast

The Candel Therapeutics, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $8.82 and $5.30. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, April 19, 2024, and so far it has risen 109.48%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for Candel Therapeutics, Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $9.02 and $8.85. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, Candel Therapeutics, Inc. finds support just below today's level at $9.02. If this is broken, then the next support from accumulated volume will be at $8.85 and $8.43.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $1.39 between high and low, or 14.68%. For the last week, the stock has had daily average volatility of 17.06%.

The Candel Therapeutics, Inc. stock is extremely overbought on RSI14 (92). Normally this may pose a good selling opportunity but since the stock has broken the trend up, the chance for a major correction due to high RSI is very small as the stock will find support at the trend broken.

Our recommended stop-loss: $10.49 (-3.16%) (This stock has very high daily movements and this gives very high risk. The RSI14 is 92 and this increases the risk substantially. There is a buy signal from a pivot bottom found 13 days ago.)

Trading Expectations (CADL) For The Upcoming Trading Day Of Thursday 9th

For the upcoming trading day on Thursday, 9th we expect Candel Therapeutics, Inc. to open at $10.37, and during the day (based on 14 day Average True Range), to move between $9.77 and $11.89, which gives a possible trading interval of +/-$1.06 (+/-9.77%) up or down from last closing price. If Candel Therapeutics, Inc. takes out the full calculated possible swing range there will be an estimated 19.55% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $9.02, some $1.81 (16.71%) from the current price of $10.83, our system finds the risk reward attractive.

Earnings coming up

Candel Therapeutics, Inc. will release earnings BMO on Thursday, May 09, 2024. We will update the financials statements for Candel Therapeutics, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 8.85% in the first trading day after earnings release.

Is Candel Therapeutics, Inc. stock A Buy?

Candel Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Opening Price for Candel Therapeutics, Inc. of Thursday, May 9, 2024

Fair opening price May 9, 2024 Current price
$10.37 ( 4.27%) $10.83

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CADL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 11.75 8.54 %
R2 11.22 3.64 %
R1 10.90 0.623 %
Current price: 10.83
Support S1 9.84 -9.16 %
S2 9.51 -12.18 %
S3 8.98 -17.07 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 10.83
Support S1 9.02 -16.71%
S2 8.85 -18.28%
S3 8.43 -22.16%

FAQ

What is the symbol for Candel Therapeutics, Inc. Stock and on which exchange is it traded?
The symbol for Candel Therapeutics, Inc. is CADL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Candel Therapeutics, Inc. Stock?
Candel Therapeutics, Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Strong Buy to a Hold/Accumulate candidate.

How to buy Candel Therapeutics, Inc. Stock?
Candel Therapeutics, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Candel Therapeutics, Inc. Stock.

What's the current price of Candel Therapeutics, Inc. Stock?
As of the end of day on the May 08, 2024, the price of an Candel Therapeutics, Inc. (CADL) share was $10.83.

What is the 52-week high and low for Candel Therapeutics, Inc. Stock?
The 52-week high for Candel Therapeutics, Inc. Stock is $46.28 and the 52-week low is $36.31.

What is the market capitalization of Candel Therapeutics, Inc. Stock?
As of the May 08, 2024, the market capitalization of Candel Therapeutics, Inc. is 281.443M.

When is the next earnings date for Candel Therapeutics, Inc.?
The upcoming earnings date for Candel Therapeutics, Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Candel Therapeutics, Inc.

Candel Therapeutics. Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, engages in the development immunotherapies for the cancer patients. The company develops CAN-2409, which is in Phase II clinical trails for the treatment of pancreatic cancer; Phase III clinical trials for the treatment of prostate cancer; and Phase II clinical trials for the treatment of lung cancer, as well as has completed Phase Ib/II clinical trials for the treatment of hi... CADL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT